France has approved use of the Oxford/AstraZeneca coronavirus vaccine in people with existing health problems aged between 65 and 74.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.


